Mekophar Chemical Pharmaceutical Joint-Stock Company
Similar suppliers you may like
Pymepharco Joint Stock Company
🇻🇳 Vietnam
19891001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
329
Key customer
MERIEUX NUTRISCIENCES
Key market
🇮🇹 Italy
Description
Pymepharco Joint Stock Company is a leading pharmaceutical manufacturer and distributor based in Tuy Hoa, Vietnam. Established as a subsidiary of the global STADA Group, the company has evolved from a local medical supplier into a major regional player with a workforce of over 1,000 employees. Pymepharco specializes in the production of high-quality generic pharmaceuticals, prescription drugs, and OTC medicines, with a particular focus on antibiotics such as Cephalosporin. Their extensive product portfolio includes analgesics, antipyretics, anti-inflammatory drugs, vitamins, minerals, and dietary supplements, as well as medical equipment and medicinal chemicals.
The company operates advanced manufacturing facilities, including the modern PME II factory, which features a production capacity of 1.2 billion tablets per shift annually. Pymepharco is distinguished as a pioneer in Vietnam for achieving EU-GMP standards, ensuring their injectable powders, tablets, soft and hard capsules, and granules meet international quality benchmarks. In addition to its own branded products, the company provides OEM services and maintains strategic partnerships with international firms like Enzymatica. As a key contributor to the Southeast Asian pharmaceutical supply chain, Pymepharco focuses on delivering affordable, high-quality healthcare solutions through sustainable development and advanced scientific applications.
Pymepharco Building
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
